- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04328597
Portuguese Inguinal Hernia Cohort (PINE) Study (PINE)
March 30, 2020 updated by: Portuguese Surgical Research Collaborative
Portuguese Inguinal Hernia Cohort Study
Prospective national cohort study of patients submitted to elective inguinal hernia repair.
The primary outcome is the prevalence of chronic postoperative inguinal pain, according to the EuraHS QoL questionnaire at 3 months postoperatively.
The study will be delivered in all Portuguese regions through a collaborative research network.
Four 2-week inclusion periods will be open for recruitment.
A site-specific questionnaire will capture procedure volume and logistical facilities for hernia surgery.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lisboa, Portugal
- Hospital Prof. Dr. Fernando Fonseca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Portuguese patients undergoing inguinal hernia repair in one of the hospitals participating in the study
Description
Inclusion Criteria:
- Elective inguinal hernia repair in a portuguese hospital
- Willing and able to consent and comply with the follow up protocol
Exclusion Criteria:
- Urgent/emergent inguinal hernia repair
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Chronic postoperative pain
Patients scoring 3 or more on the EuraHS Quality of Life assessment after elective inguinal hernia repair
|
Inguinal hernia repair (open, laparo-endoscopic, robotic)
Other Names:
|
|
Non chronic postoperative pain
Patients scoring less than 3 on the EuraHS Quality of Life assessment after elective inguinal hernia repair
|
Inguinal hernia repair (open, laparo-endoscopic, robotic)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Chronic postoperative pain
Time Frame: 3 months postoperatively
|
Score of 3 or above on the pain domains of the European Registry for Abdominal Wall Hernias Quality of Life (EuraHS QoL) assessment, with higher scores indicating higher pain
|
3 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Postoperative morbidity
Time Frame: 30 days after surgery
|
30 days after surgery
|
|
Proportion of patients receiving antibiotic prophylaxis before inguinal hernia repair
Time Frame: Intraoperatively
|
Intraoperatively
|
|
Proportion of patients operated as day case surgery
Time Frame: 30 days after surgery
|
30 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Chair: Antonio Soares, Portuguese Surgical Research Collaborative
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 7, 2019
Primary Completion (Anticipated)
June 12, 2020
Study Completion (Anticipated)
August 12, 2020
Study Registration Dates
First Submitted
March 25, 2020
First Submitted That Met QC Criteria
March 30, 2020
First Posted (Actual)
March 31, 2020
Study Record Updates
Last Update Posted (Actual)
April 1, 2020
Last Update Submitted That Met QC Criteria
March 30, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Version 1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No plans are made to share patient data
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.